TP53 and neoplasm: Previous studies identified p53, an important tumor suppressor, as a bona fide client of the Hsp70 system.43, 44, 45 Mutation of the DNAJA1 farnesylation site renders p53 unstable and initially suggested that preventing DNAJA1 farnesylation may be a viable anticancer strategy.46